🔎 Trials Near Me

Nyumbani › COPD › Texas › Dallas

Majaribio ya kliniki ya COPD katika Dallas, TX

Masomo 12 ya COPD yanatafuta washiriki katika vituo vya Dallas na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

InaajiriHatua 3
  • Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
Umri 40 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07190209

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Inaajiri
  • University of Texas Southwestern, Dallas
Umri 40 hadi 80 · Jinsia zote · Imesasishwa 17 Sep 2026 · NCT06035120

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

InaajiriHatua 2
  • Research Site, Dallas
Umri 40 na zaidi · Jinsia zote · Imesasishwa 9 Sep 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

InaajiriHatua 3
  • Research Site, Dallas
Umri 40 hadi 80 · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

InaajiriHatua 2/3
  • Alina Clinical Trials, LLC., Dallas
Umri 35 hadi 80 · Jinsia zote · Imesasishwa 31 Ago 2026 · NCT07363694

STRIVE Post-Market Registry Study

InaajiriUtafiti wa uchunguzi
  • Baylor Scott & White Research Institute, Dallas
  • University of Texas Southwestern, Dallas
Umri 18 na zaidi · Jinsia zote · Imesasishwa 3 Ago 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

InaajiriHatua 3
  • GSK Investigational Site, Dallas
Umri 40 hadi 75 · Jinsia zote · Imesasishwa 28 Jul 2026 · NCT07177339

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

InaajiriUtafiti wa uchunguzi
  • Liver Center of Texas, Dallas
Umri 18 na zaidi · Jinsia zote · Imesasishwa 10 Jul 2026 · NCT05181826

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

InaajiriHatua 3
  • GSK Investigational Site, Dallas
Umri 40 hadi 80 · Jinsia zote · Imesasishwa 9 Apr 2026 · NCT06961214

Majaribio ya COPD katika miji mingine

Masomo mengine katika Dallas

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.